2026 International Congress Archives - Page 160 of 208

Racial Disparities in End-of-Life Care among Patients with Advanced Movement Disorders in an Interdisciplinary Supportive Care Clinic

K. Sugiura, M. Tharp, M. Husain, A. Hong, Y. Chen, A. Naveed, D. Shankar, K. Gustashaw, S. Chen, G. Hong, J. Fleisher, N. Kramer (Chicago, USA)
Raman Spectroscopic Identification of Biochemical Alterations in Post Mortem Brain Tissue Microarrays from Parkinsons and Alzheimers Disease

A. Omirude, A. Yusuf, S. Eze (Zaria, Nigeria)
Randomized Controlled Trial Comparing Adaptive versus Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease; Closed Loop Optimization of Deep Brain Stimulation Effect in Parkinson’s Disease (CLOSE-PD study)

J. Genet, M. Heeren, B. Keulen, D. Hubers, B. Swinnen, F. Contarino, M. Janssen, Y. Temel, B. van Wijk, A. Hillebrand, M. Bot, R. Schuurman, R. de Bie, M. Beudel (Leuven, Belgium)
Rare GBA c.1157T>G (p.F386C) Variant in Parkinson’s Disease. Case study.

G. Mussagaliyeva, ZH. Myrzayev, CH. Shashkin, D. Bagautdinov, A. Muratbaikyzy (Almaty, Kazakhstan)
Rare Heterozygous SLC25A12 Variants Are Associated with Parkinson’s Disease

K. Senkevich, T. Kleinz, N. Brüggemann, ZH. Fang, Z. Gan-Or, N. Mencacci, C. Blauwendraat, H. Morris, S. Judd, T. Gasser, K. Brockmann, P. Pastor, C. Beetz, P. Bauer, P. Heutink, K. Seppi, F. Krismer, C. Klein, J. Trinh, A. Zimprich (Montreal, Canada)
Rare Neurotoxicity of Cotrimoxazole A Movement Disorder Presentation In Elderly Patient

M. Keita Sr, A. Ouedraogo, E E. Fanorena, C. Bekara, M. Abdallah (Bourges, France)
Rare Observations of Sustained Symptomatic Improvement with Botulinum Toxin Type A Injections in Facial and Cervical Dystonia: Case Series

N. Rozenberg, G. Yahalom, D. Segal, L. Barski, V. Livneh, A. Ezra, R. Alcalay, T. Gurevich (Tel Aviv, Israel)
Rare Variant Analysis in Parkinson’s Disease Patients Stratified by Polygenic Risk

S. Kanagasingam, A. Balan, Z. Gan-Or, K. Senkevich (Montréal, Canada)
Rates Of Phenoconvertion And Progression To Functionally Meaningful Impairment In NSD Stage 2B Participants: PPMI cohort

T. Simuni, C. Coffey, M. Brumm, C. Choi, R. Schneider, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, K. Marek (Iowa City, USA)
Re-emerging and Emerging Tremor with Postural Changes in Tremor in Dystonia

R. Carandang, P. Panyakeaw (Bangkok, Thailand)